Deletion of FGFR1 in hypothalamic neurons alters energy homeostasis and negates the metabolic effects of α-Klotho
Endocrinology · 2025
DOI: 10.1210/endocr/bqaf182 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, 2025. Verfasst von Daniel Shookster und 5 weiteren Autor:innen. Beteiligte Einrichtung: East Carolina Diabetes and Obesity Institute, East Carolina University, Greenville, NC 27834, USA. Hauptthemen laut MEDLINE: Receptor, Fibroblast Growth Factor, Type 1, Energy Metabolism, Homeostasis, Neurons. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Background
The global obesity epidemic necessitates the identification of novel therapeutic targets. Although central administration of α-Klotho improves metabolic function in rodents, its precise mechanisms of action remain unclear. Since α-Klotho signals through fibroblast growth factor receptors (FGFRs), we hypothesized that FGFR1 within specific hypothalamic neuronal populations is critical for maintaining metabolic homeostasis.
Methods
We investigated the metabolic role of FGFR1 in the arcuate nucleus of adult mice using an adeno-associated virus (AAV)-mediated CRISPR/Cas9 system, in conjunction with transgenic models, to achieve cell-type-specific knockout of FGFR1 in mature glutamatergic, gamma-aminobutyric acid (GABA)ergic, and agouti-related peptide (AgRP) neurons.
Results
We found that FGFR1 governs distinct metabolic functions in different neuronal populations. Conditional deletion of FGFR1 in glutamatergic neurons impaired glucose tolerance. In contrast, its ablation in GABAergic neurons induced a severe energy imbalance, resulting in obesity characterized by significant weight gain and adiposity. Notably, AgRP neuron-specific deletion of FGFR1 recapitulated this obese phenotype. Furthermore, the loss of FGFR1 in AgRP neurons disrupted α-Klotho signaling, preventing its ability to modulate AgRP neuron activity and abolishing its beneficial effects on glucose and energy metabolism.
Conclusion
Our results establish FGFR1 in hypothalamic neurons as an essential component of the pathway through which α-Klotho regulates systemic energy balance. These findings identify hypothalamic FGFR1 as a critical molecular target for developing anti-obesity therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- East Carolina Diabetes and Obesity Institute, East Carolina University, Greenville, NC 27834, USA.
- Department of Kinesiology, East Carolina University, Greenville, NC 27858, USA.
- Human Performance Laboratory, College of Human Performance and Health, East Carolina University, Greenville, NC 27858, USA.
- Department of Physiology, East Carolina University, Greenville, NC 27834, USA.
ORCID-Profile: Hu Huang
Förderung
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Shookster, D., Landry, T., Bunner, W., O'Connell, S., Darshan, P., & Huang, H. (2025). Deletion of FGFR1 in hypothalamic neurons alters energy homeostasis and negates the metabolic effects of α-Klotho. Endocrinology. https://doi.org/10.1210/endocr/bqaf182
Vancouver
Shookster D, Landry T, Bunner W, O'Connell S, Darshan P, Huang H. Deletion of FGFR1 in hypothalamic neurons alters energy homeostasis and negates the metabolic effects of α-Klotho. Endocrinology. 2025. doi:10.1210/endocr/bqaf182
BibTeX
@article{Shookster2025,
author = {Shookster, Daniel and Landry, Taylor and Bunner, Wyatt and O'Connell, Shea and Darshan, Patel and Huang, Hu},
title = {Deletion of FGFR1 in hypothalamic neurons alters energy homeostasis and negates the metabolic effects of α-Klotho},
journal = {Endocrinology},
year = {2025},
doi = {10.1210/endocr/bqaf182}
}
EUVIMED